27-mg + 18-mg | = | Just one 45-mg extended-release tablet |
36-mg + 27-mg | = | Just one 63-mg extended-release tablet |
36-mg + 36-mg | = | Just one 72-mg extended-release tablet |
RELEXXII Offers You The Power To Choose
RELEXXII (methylphenidate hydrochloride extended-release tablets) is available in seven dosing options, including two “in-between” strengths, to personalize once-daily dosing needs.
Dosing and Administration1
RELEXXII tablets should be taken orally once daily in the morning, with or without food.
RELEXXII tablets must be swallowed whole with the aid of liquids and must not be chewed, divided, or crushed.
Dosage Recommendations for RELEXXII in Pediatric Patients 6 to 17 Years and Adults
Patient Population | Recommended RELEXXII Starting Dosage |
RELEXXII Dosage Range |
---|
Pediatric Patients
6 to 12 years | 18-mg once daily | 18-mg to 54-mg once daily |
13 to 17 years | 18-mg once daily |
18-mg to 72-mg once daily (not to exceed 2-mg/kg/day) |
Adults
18 (up to 65 years) | 18-mg or 36-mg once daily | 18-mg to 72-mg once daily |
Dosage Recommendations for Patients Converting from Methylphenidate
Regimens to RELEXXII
Current Methylphenidate Daily Dosage | Recommended RELEXXII Starting Dosage |
5-mg methylphenidate twice daily or three times daily | 18-mg once daily in the morning |
10-mg methylphenidate twice daily or three times daily | 36-mg once daily in the morning |
15-mg methylphenidate twice daily or three times daily | 54-mg once daily in the morning |
20-mg methylphenidate twice daily or three times daily | 72-mg once daily in the morning |
With seven dosing options from which to choose, patients can take just one RELEXXII tablet per day to get the personalized dose they need.
Traditional Way of Dosing
Two tablets taken once daily.
More tablets could mean higher costs.
VS
RELEXXII Way of Dosing
Just one tablet once a day makes getting the right dose more affordable and convenient.
References: 1. RELEXXII (methylphenidate hydrochloride extended-release tablets) package insert. Vertical Pharmaceuticals, LLC; 2024.
*Co-pay assistance is applicable to prescription coverage for eligible commercially insured patients. Offer void where prohibited. No income restrictions apply. Other restrictions may apply. Offer effective 04/2024. Alora Pharmaceuticals, LLC reserves the right to rescind, revoke, or amend this offer without notice. For full terms and conditions, click here.